Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended 31 March 2025 to BSE, as mandated under SEBI's Listing Regulations. The report was issued by practicing company secretary Haresh Kapuriya of KH & Associates on 18 April 2025. It confirms that the company has fully complied with all applicable SEBI regulations and circulars reviewed, including Listing Obligations, Insider Trading rules, and Secretarial Standards. No deviations, penalties, or actions by SEBI or stock exchanges were reported against the company, its promoters, directors, or subsidiaries. All 12 compliance checkpoints — covering website disclosures, related-party transactions, director disqualifications, performance evaluations, and insider trading — were marked compliant with no observations.
This is a routine annual compliance filing with a clean report, reflecting sound corporate governance practices. It carries no immediate price impact but reassures investors about regulatory standing.